title: Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.
abstract: During phase II metabolism, a substrate is rendered more hydrophilic through the covalent attachment of an endogenous molecule. The cytosolic sulfotransferase (SULT) and UDP-glucuronosyltransferase (UGT) families of enzymes account for the majority of phase II metabolism in humans and animals. In general, phase II metabolism is considered to be a detoxication process, as sulfate and glucuronide conjugates are more amenable to excretion and elimination than are the parent substrates. However, certain products of phase II metabolism (e.g., unstable sulfate conjugates) are genotoxic. Members of the nuclear receptor superfamily are particularly important regulators of SULT and UGT gene transcription. In metabolically active tissues, increasing evidence supports a major role for lipid-sensing transcription factors, such as peroxisome proliferator-activated receptors (PPARs), in the regulation of rodent and human SULT and UGT gene expression. This review summarizes current information regarding the regulation of these two major classes of phase II metabolizing enzyme by PPARs.
authors.affiliation: Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA. m.runge-morris@wayne.edu
authors.forename: Melissa
authors.initials: M
authors.lastname: Runge-Morris
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Kocarek
references.citation: Drug Metab Dispos. 2005 Jul;33(7):1017-26
references.pmid: 15802387
references.citation: Drug Metab Dispos. 2005 Jan;33(1):147-56
references.pmid: 15502011
references.citation: Pharmacogenet Genomics. 2007 Dec;17(12):1077-89
references.pmid: 18004212
references.citation: Endocrinology. 2001 Jul;142(7):2978-84
references.pmid: 11416019
references.citation: Curr Drug Metab. 2000 Jul;1(1):1-30
references.pmid: 11467078
references.citation: J Invest Dermatol. 1999 Mar;112(3):303-9
references.pmid: 10084306
references.citation: Pharmacol Ther. 1989;43(2):261-89
references.pmid: 2506584
references.citation: J Pharmacol Exp Ther. 2001 May;297(2):489-95
references.pmid: 11303034
references.citation: Curr Drug Metab. 2005 Aug;6(4):289-98
references.pmid: 16101569
references.citation: Endocrinology. 1993 Nov;133(5):2177-86
references.pmid: 8404669
references.citation: J Steroid Biochem Mol Biol. 1995 Jun;52(6):529-39
references.pmid: 7779757
references.citation: Mutat Res. 2000 Apr;462(2-3):189-95
references.pmid: 10767630
references.citation: J Lipid Res. 1983 Feb;24(2):131-40
references.pmid: 6833890
references.citation: Genomics. 1998 Nov 1;53(3):284-95
references.pmid: 9799594
references.citation: J Invest Dermatol. 1984 Nov;83(5):332-5
references.pmid: 6238102
references.citation: Pharmacol Ther. 2009 Jun;122(3):246-63
references.pmid: 19318113
references.citation: Drug Metab Dispos. 2002 Nov;30(11):1280-7
references.pmid: 12386136
references.citation: Toxicol In Vitro. 2000 Dec;14(6):505-12
references.pmid: 11033061
references.citation: J Clin Endocrinol Metab. 1999 Apr;84(4):1357-64
references.pmid: 10199779
references.citation: Drug Metab Dispos. 2000 Jan;28(1):34-7
references.pmid: 10611137
references.citation: Structure. 2002 Dec;10(12):1697-707
references.pmid: 12467577
references.citation: Xenobiotica. 1987 Apr;17(4):445-57
references.pmid: 2885979
references.citation: Biochem Pharmacol. 1987 Nov 15;36(22):3923-7
references.pmid: 3120730
references.citation: Methods Enzymol. 2005;400:1-22
references.pmid: 16399340
references.citation: Drug Metab Dispos. 2006 Nov;34(11):1887-92
references.pmid: 16896063
references.citation: Biochim Biophys Acta. 1994 Nov 17;1215(1-2):183-9
references.pmid: 7948002
references.citation: Angew Chem Int Ed Engl. 2004 Jul 5;43(27):3526-48
references.pmid: 15293241
references.citation: J Clin Invest. 1998 Sep 1;102(5):1016-23
references.pmid: 9727070
references.citation: Steroids. 1998 May-Jun;63(5-6):322-8
references.pmid: 9618795
references.citation: Drug Metab Dispos. 2002 Dec;30(12):1462-9
references.pmid: 12433820
references.citation: Mol Endocrinol. 2003 Jun;17(6):985-93
references.pmid: 12690094
references.citation: Chem Biol Interact. 1998 Feb 20;109(1-3):329-39
references.pmid: 9566756
references.citation: Dig Liver Dis. 2007 Apr;39(4):351-5
references.pmid: 17347060
references.citation: Biochem Biophys Res Commun. 2000 Oct 14;277(1):236-45
references.pmid: 11027669
references.citation: J Invest Dermatol. 1992 May;98(5):730-3
references.pmid: 1349030
references.citation: J Steroid Biochem Mol Biol. 1999 Jul-Aug;70(1-3):101-8
references.pmid: 10529008
references.citation: J Invest Dermatol. 1989 Feb;92(2):203-9
references.pmid: 2465352
references.citation: Clin Pharmacokinet. 1999 Aug;37(2):91-104
references.pmid: 10496299
references.citation: Biochem J. 2004 May 1;379(Pt 3):533-40
references.pmid: 14741047
references.citation: Mol Pharmacol. 1999 Dec;56(6):1198-206
references.pmid: 10570047
references.citation: Mol Cell Biol. 1998 Sep;18(9):5199-207
references.pmid: 9710604
references.citation: J Biol Chem. 1992 Feb 15;267(5):3257-61
references.pmid: 1339448
references.citation: Clin Sci (Lond). 1984 Apr;66(4):389-97
references.pmid: 6697662
references.citation: Hepatology. 2007 Feb;45(2):422-32
references.pmid: 17256725
references.citation: Drug Metab Dispos. 2006 Oct;34(10):1772-8
references.pmid: 16855052
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14033-7
references.pmid: 11717462
references.citation: Biochem Biophys Res Commun. 2001 Oct 19;288(1):280-9
references.pmid: 11594786
references.citation: Brain Res. 2001 Nov 30;920(1-2):222-5
references.pmid: 11716829
references.citation: Biochem J. 1982 Apr 1;203(1):161-8
references.pmid: 7103935
references.citation: FEBS Lett. 2001 Feb 9;490(1-2):39-43
references.pmid: 11172807
references.citation: Drug Metab Dispos. 1999 May;27(5):588-95
references.pmid: 10220487
references.citation: Biochim Biophys Acta. 1985 Oct 17;842(2-3):202-13
references.pmid: 3931693
references.citation: Hepatology. 2006 Aug;44(2):368-78
references.pmid: 16871576
references.citation: Pharmacogenomics J. 2004;4(1):54-65
references.pmid: 14676822
references.citation: Nat Med. 2005 Feb;11(2):153-9
references.pmid: 15685171
references.citation: J Biol Chem. 2003 May 16;278(20):17838-44
references.pmid: 12637555
references.citation: J Biol Chem. 2003 Nov 7;278(45):44593-9
references.pmid: 12923182
references.citation: J Pharmacol Exp Ther. 2006 Mar;316(3):1310-7
references.pmid: 16339912
references.citation: Biochim Biophys Acta. 1996 Mar 15;1289(2):284-90
references.pmid: 8600986
references.citation: Annu Rev Pharmacol Toxicol. 2000;40:159-76
references.pmid: 10836131
references.citation: Xenobiotica. 1987 Jun;17(6):669-77
references.pmid: 3114967
references.citation: Toxicol Appl Pharmacol. 1999 Feb 15;155(1):1-12
references.pmid: 10036213
references.citation: J Toxicol Sci. 2000 Dec;25(5):433-41
references.pmid: 11201174
references.citation: Curr Drug Metab. 2000 Sep;1(2):143-61
references.pmid: 11465080
references.citation: J Histochem Cytochem. 2003 Dec;51(12):1655-64
references.pmid: 14623933
references.citation: J Pharmacol Exp Ther. 2007 Nov;323(2):586-98
references.pmid: 17687072
references.citation: Fertil Steril. 2010 Mar 15;93(5):1538-44
references.pmid: 19243756
references.citation: Anal Biochem. 2003 Dec 1;323(1):139-49
references.pmid: 14622968
references.citation: J Endocrinol. 2001 Dec;171(3):525-32
references.pmid: 11739018
references.citation: Biochem Biophys Res Commun. 2008 Oct 31;375(4):531-5
references.pmid: 18725199
references.citation: J Biol Chem. 2002 Jul 12;277(28):25125-32
references.pmid: 11991950
references.citation: Biochim Biophys Acta. 2005 Jun 20;1724(1-2):119-26
references.pmid: 15878639
references.citation: Mol Cell Biochem. 2009 Jun;326(1-2):3-8
references.pmid: 19130183
references.citation: Biochem Biophys Res Commun. 1998 Jun 29;247(3):681-6
references.pmid: 9647753
references.citation: Carcinogenesis. 1991 Jun;12(6):1145-7
references.pmid: 2044198
references.citation: Fundam Clin Pharmacol. 1988;2(4):259-65
references.pmid: 3220422
references.citation: J Pharmacol Exp Ther. 2008 Feb;324(2):612-21
references.pmid: 17993606
references.citation: Curr Drug Metab. 2008 Feb;9(2):99-105
references.pmid: 18288952
references.citation: J Invest Dermatol. 2004 May;122(5):1207-13
references.pmid: 15140224
references.citation: Pharmacogenetics. 2001 Jun;11(4):357-68
references.pmid: 11434514
references.citation: J Biol Chem. 2003 Aug 29;278(35):32852-60
references.pmid: 12810707
references.citation: Drug Metab Dispos. 2007 Mar;35(3):419-27
references.pmid: 17151188
references.citation: J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):214-21
references.pmid: 17055258
references.citation: J Biol Chem. 2002 Sep 27;277(39):36161-6
references.pmid: 12145317
references.citation: Mol Aspects Med. 2009 Jun;30(3):134-52
references.pmid: 19248804
references.citation: Biochem J. 1989 Jun 15;260(3):641-6
references.pmid: 2764897
references.citation: J Invest Dermatol. 1998 Dec;111(6):973-81
references.pmid: 9856804
references.citation: Biochem J. 2000 Mar 15;346 Pt 3:857-64
references.pmid: 10698717
references.citation: Cancer Res. 1996 Apr 1;56(7):1551-5
references.pmid: 8603401
references.citation: Mutat Res. 2001 Oct 1;482(1-2):27-40
references.pmid: 11535246
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2577-80
references.pmid: 10404840
references.citation: Carcinogenesis. 1998 Nov;19(11):2049-53
references.pmid: 9855023
references.citation: Gene. 2006 Feb 15;367:66-73
references.pmid: 16368200
references.citation: Endocrinology. 1991 Sep;129(3):1375-81
references.pmid: 1874177
references.citation: Drug Metab Dispos. 2008 Jan;36(1):51-5
references.pmid: 17908920
references.citation: J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):171-7
references.pmid: 18586095
references.citation: Annu Rev Pharmacol Toxicol. 2000;40:581-616
references.pmid: 10836148
references.citation: Circulation. 2004 Jan 6;109(1):92-6
references.pmid: 14676143
references.citation: Hepatology. 2006 Nov;44(5):1158-70
references.pmid: 17058234
references.citation: J Biol Chem. 2004 May 21;279(21):22250-7
references.pmid: 15004017
references.citation: Arch Biochem Biophys. 1995 Dec 20;324(2):267-72
references.pmid: 8554318
references.citation: Psychoneuroendocrinology. 1998 Nov;23(8):963-87
references.pmid: 9924747
references.citation: Drug Metab Dispos. 2003 Mar;31(3):326-33
references.pmid: 12584160
references.citation: Nature. 1965 Nov 27;208(5013):856-8
references.pmid: 5870099
references.citation: Toxicol Sci. 2006 Mar;90(1):5-22
references.pmid: 16322073
references.citation: Endocrinology. 2003 Apr;144(4):1186-93
references.pmid: 12639899
references.citation: Chem Biol Interact. 1991;77(1):97-105
references.pmid: 1898504
references.citation: Mol Pharmacol. 2005 Apr;67(4):1257-67
references.pmid: 15635043
references.citation: J Biol Chem. 2003 Apr 18;278(16):13975-83
references.pmid: 12582161
references.citation: J Histochem Cytochem. 1973 Nov;21(11):967-71
references.pmid: 4587529
references.citation: Pharmacogenetics. 1992 Jun;2(3):93-108
references.pmid: 1306114
references.citation: Pharmacogenetics. 1997 Aug;7(4):255-69
references.pmid: 9295054
references.citation: Gen Pharmacol. 1989;20(4):407-12
references.pmid: 2502468
references.citation: Neurosci Lett. 2008 Jan 3;430(1):75-80
references.pmid: 18054434
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13801-6
references.pmid: 12370413
references.citation: Cell Growth Differ. 1995 Dec;6(12):1619-26
references.pmid: 9019167
references.citation: Drug Metab Pharmacokinet. 2006 Aug;21(4):315-23
references.pmid: 16946559
references.citation: Drug Metab Dispos. 1996 Dec;24(12):1328-35
references.pmid: 8971138
references.citation: Endocr Rev. 2002 Oct;23(5):703-32
references.pmid: 12372849
references.citation: Dev Biol. 1997 Sep 1;189(1):22-32
references.pmid: 9281334
references.citation: J Biol Chem. 2004 Apr 2;279(14):14033-8
references.pmid: 14722075
references.citation: Hepatology. 2007 Jan;45(1):128-38
references.pmid: 17187418
references.citation: J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51
references.pmid: 12023536
references.citation: Steroids. 2001 Jun;66(6):473-9
references.pmid: 11182136
references.citation: J Invest Dermatol. 1998 Dec;111(6):1098-102
references.pmid: 9856823
references.citation: Mol Endocrinol. 2006 Apr;20(4):795-808
references.pmid: 16357103
references.citation: J Clin Endocrinol Metab. 1994 Jan;78(1):234-6
references.pmid: 8288708
references.citation: Biochem Pharmacol. 1977 Mar 15;26(6):547-9
references.pmid: 403920
references.citation: Biochem J. 2001 Jun 15;356(Pt 3):891-7
references.pmid: 11389699
references.citation: J Lipid Res. 2005 Dec;46(12):2657-66
references.pmid: 16150827
references.citation: J Pharmacol Exp Ther. 1995 Jun;273(3):1551-9
references.pmid: 7791131
references.citation: Toxicology. 2004 Nov 15;204(2-3):109-21
references.pmid: 15388238
references.citation: Int J Biochem Cell Biol. 2004 Jul;36(7):1141-6
references.pmid: 15109560
references.citation: Toxicol Appl Pharmacol. 2003 Sep 1;191(2):130-46
references.pmid: 12946649
references.citation: Toxicol Appl Pharmacol. 1992 Aug;115(2):261-7
references.pmid: 1641859
references.citation: J Am Acad Dermatol. 1984 May;10(5 Pt 1):866-8
references.pmid: 6586754